Here begins the text.

The PDG 30th Anniversary Symposium - The History and Future Perspective of PDG -


  Ministry of Health, Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) will host the international symposium, entitled “The PDG 30th Anniversary Symposium -The History and Future Perspective of PDG”.
  The Pharmacopoeial Discussion Group (PDG) will celebrate its 30th anniversary this year in 2019. In conjunction with the PDG face-to-face meeting being held in Tokyo this year, the PDG 30th Anniversary Symposium will be held as a milestone. At this symposium, we will look back on the history of PDG's 30 years of activities, and give a lecture from experts on the latest situation and the role PDG has played in Europe, Japan, the United States, and the other country/region. Representatives of PDG members (the European Pharmacopoeia: EP, the Japanese Pharmacopoeia: JP and the United States Pharmacopeia: USP) will give a lecture on the latest topics of each pharmacopoeia and PDG observers, the World Health Organization (WHO), will speak on the relationship between the International Meeting of World Pharmacopoeia and PDG along with the expectations for PDG, which makes stakeholder share the trends and future perspective of each pharmacopoeia. Furthermore, among the pharmacopoeia users, experts from pharmaceutical industry groups will talk about their expectations for PDG. In addition, experts involved in the drafting of the Japanese Pharmacopoeia will introduce you to the hot topics and the latest activity of PDG.


Ministry of Health, Labour and Welfare (MHLW)
Pharmaceuticals and Medical Devices Agency (PMDA)

Date and Time

Thursday, October 3, 2019 13:30~16:40 (Reception desk to open at 13:00)

Location and Access

Seiryo-Kaikan Hall
2nd floor, Seiryo-Kaikan, 2-16-2, Nagata-chou, Chiyoda-ku, Tokyo
Access map:  (Available only in Japanese)


Simultaneous interpretation (Japanese-English and English-Japanese) will be provided.
Moderator:Mr. Kenichi Mikami (Director, Office of Review Management, PMDA)


Contents, Speakers


Opening remarks

Mr. Kazuhiko Mori
(Minister’s Secretariat, Councilor for Pharmaceutical Affairs, MHLW)


The history of PDG

Ms. Fumi Yamamoto (Director, Pharmaceutical Evaluation Division,
Pharmaceutical Safety and Environmental Health Bureau, MHLW)


Introduction and expectation for PDG from each pharmacopoeia

EP: Dr. Susanne Keitel (Director, European Directorate for the Quality of Medicines)
JP: Dr. Takao Yamori (Executive Director, PMDA)
USP: Dr. Jaap Venema (Chief Science Officer & Chair, Council of Experts, USP)


Expectation for PDG from WHO

Dr. Sabine Kopp
(Group Lead, Medicines Quality Assurance, World Health Organization)




Expectation for PDG from Stakeholders

Speaker Undecided (The European Federation of Pharmaceutical Industries and Associations/ The Pharmaceutical Research and Manufacturers of America)

Ms. Priscilla Zawislak (President, International Pharmaceutical Excipients Council)
To be decided


Hot topics and latest activity of PDG

Dr. Haruhiro Okuda (Chair of Expert Committee, Japanese Pharmacopoeia)


Closing remarks

Dr. Yoshikazu Hayashi (Senior Executive Director, PMDA)

Program (contents, speakers and time schedule) may change due to circumstances.


  There is no registration fee for this symposium. Please register through the following website by the end of September. It will be closed as soon as the capacity is reached, so please apply early if you wish to participate. If you send the registration form from the website, you will receive via e-mail the certification ticket, which should be printed out and presented with you at the reception on the day of the symposium. If you do not receive the certification ticket, please contact us by e-mail at the address below.
Registration form:


Symposium Secretariat
E-mail: pdg30symposium● (please replace ● to @ when you send an email)

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.